Takeda Pharmaceutical (TAK) Gross Margin (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Gross Margin of 66.66% for the quarter ended Jun 30, 2026, down 3.97 percentage points from 70.63% a year earlier and unchanged from the prior quarter.
Takeda Pharmaceutical (TAK) Gross Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Takeda Pharmaceutical was 65.77%, down 1.01 percentage points year-over-year; for the year ended Mar 31, 2026, it was 18.05%, up 0.13 percentage points from the prior year.
- Annual Gross Margin shows a five-year change of -50.86 percentage points (years ended Mar 2021 to Mar 2026).
- In prior years, Takeda Pharmaceutical's Gross Margin was 17.92% in the year ended Mar 31, 2025 (-1.34 pp), 19.26% in the year ended Mar 31, 2024 (+0.94 pp), 18.31% in the year ended Mar 31, 2023 (-50.68 pp) and 68.99% in the year ended Mar 31, 2022 (+0.08 pp).
- Quarterly Gross Margin has run from a low of 58.95% in the quarter ended Dec 31, 2022 to a high of 213.21% in the quarter ended Sep 30, 2022 over five years.
- On a year-over-year basis, Gross Margin has declined in each of the last three quarters, with an average year-over-year change of -0.19 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Gross Margin in the past five years was the quarter ended Jun 30, 2025, with a gain of 5.92 percentage points; the weakest was the quarter ended Sep 30, 2023, with a drop of 145.71 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 66.66% (quarter ended Mar 31, 2026), 62.93% (quarter ended Dec 31, 2025) and 66.04% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 66.66% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.66% |
| Mar 31, 2026 | 66.66% |
| Dec 31, 2025 | 62.93% |
| Sep 30, 2025 | 66.04% |
| Jun 30, 2025 | 70.63% |
| Mar 31, 2025 | 67.96% |
| Dec 31, 2024 | 63.73% |
| Sep 30, 2024 | 66.04% |
| Jun 30, 2024 | 64.71% |
| Mar 31, 2024 | 67.96% |
| Dec 31, 2023 | 63.60% |
| Sep 30, 2023 | 67.50% |
| Jun 30, 2023 | 66.08% |
| Mar 31, 2023 | 69.67% |
| Dec 31, 2022 | 58.95% |
| Sep 30, 2022 | 213.21% |
| Jun 30, 2022 | 71.66% |
| Mar 31, 2022 | 69.88% |
| Jun 30, 2021 | 74.59% |
| Mar 31, 2021 | 67.10% |
Takeda Pharmaceutical Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();